| 000 -LEADER |
|---|
| fixed length control field |
02752cam a22005055i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
19005780 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220708114148.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160307s2016 flua b 001 0 eng c |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2016004874 |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
101704311 |
| Source |
DNLM |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780367828912 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocn936350306 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Transcribing agency |
DLC |
| Description conventions |
rda |
| Modifying agency |
BTCTA |
| -- |
BDX |
| -- |
YDXCP |
| -- |
OCLCF |
| -- |
GZM |
| -- |
NLM |
| -- |
OCLCO |
| -- |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
2017 C-661 |
|
|---|
| Classification number |
QV 771.4 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.50724 |
| Item number |
YUA-B |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Yuan, Ying |
| Titles and words associated with a name |
(Professor of biostatistics) |
| 9 (RLIN) |
30533 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Bayesian designs for phase I-II clinical trials / |
| Statement of responsibility, etc. |
Ying Yuan, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA; Hoang Q. Nguyen,The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA; Peter F. Thall The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 310 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
24 cm |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Clinical trials |
| General subdivision |
Statistical methods. |
| 9 (RLIN) |
30534 |
|
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Testing |
| -- |
Statistical methods. |
| 9 (RLIN) |
30535 |
|
|---|
| Topical term or geographic name as entry element |
Bayesian statistical decision theory. |
| 9 (RLIN) |
30419 |
|
|---|
| Topical term or geographic name as entry element |
Clinical Trials, Phase I as Topic. |
| 9 (RLIN) |
30536 |
|
|---|
| Topical term or geographic name as entry element |
Clinical Trials, Phase II as Topic. |
| 9 (RLIN) |
30537 |
|
|---|
| Topical term or geographic name as entry element |
Statistics as Topic. |
| 9 (RLIN) |
30538 |
|
|---|
| Topical term or geographic name as entry element |
Bayes Theorem. |
| 9 (RLIN) |
30539 |
|
|---|
| Topical term or geographic name as entry element |
Dose-Response Relationship, Drug. |
| 9 (RLIN) |
30540 |
|
|---|
| Topical term or geographic name as entry element |
Bayesian statistical decision theory. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00829019 |
| 9 (RLIN) |
30419 |
|
|---|
| Topical term or geographic name as entry element |
Clinical trials |
| General subdivision |
Statistical methods. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00864440 |
| 9 (RLIN) |
30534 |
|
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Testing |
| -- |
Statistical methods. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00898954 |
| 9 (RLIN) |
30535 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nguyen, Hoang Q., |
| 9 (RLIN) |
30541 |
|
|---|
| Personal name |
Thall, Peter F., |
| 9 (RLIN) |
30542 |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Boca Raton : |
| Name of producer, publisher, distributor, manufacturer |
CRC Press,Taylor & Francis Group, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2016. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Chapman & Hall/CRC Biostatistics series |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references (pages 283-300) and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Why conduct phase I-II trials? -- The phase I-II paradigm -- Establishing priors -- Efficacy-toxicity trade-off-based designs -- Designs with late-onset outcomes -- Utility-based designs -- Personalized dose finding -- Combination trials -- Optimizing molecularly targeted agents -- Optimizing doses in two cycles -- Optimizing dose and schedule -- Dealing with dropouts -- Optimizing intra-arterial tPA -- Optimizing sedative dose in preterm infants. |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
pccadap |
| d |
2 |
| e |
epcn |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Reference |
